Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.75.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.11.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBF.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BZ.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.10.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.44NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.4.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.5.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.37NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-21388.1US
BA.5.2.57NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CN.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.54NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.52NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BL.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.11.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.48NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JQ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.10.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BL.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BL.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CC.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BZ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CK.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.34NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.35NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAY.2.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.1.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.36NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BV.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.33NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used